DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Acamprosate Calcium/Baclofen

Generic Name: Acamprosate Calcium/Baclofen

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion

Phase 2

Completed

Posted: 2015/02/11

Sponsor:

Pharnext S.C.A.

Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD)

Phase 2

Completed

Posted: 2015/02/11

Sponsor:

Pharnext S.C.A.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

Pharnext's CMT1A Drug PXT3003 Fails to Meet Primary Endpoint in Phase 3 PREMIER Trial

3 months ago

French biotech Pharnext's lead drug PXT3003 for Charcot-Marie-Tooth disease type 1A failed to demonstrate superiority over placebo in Phase 3 PREMIER trial due to unexpected placebo response.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy